A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) | Clinical Research Trial Listing ( Nonalcoholic Steatohepatitis (NASH) ) ( NCT04104321 )
![PBC NASH on Twitter: "ARREST: Phase IIb trial of aramchol in noncirrhotic patients with NASH is under way. #PBCNASH http://t.co/nESuRWVrrF" / Twitter PBC NASH on Twitter: "ARREST: Phase IIb trial of aramchol in noncirrhotic patients with NASH is under way. #PBCNASH http://t.co/nESuRWVrrF" / Twitter](https://pbs.twimg.com/media/CDarqU2WEAA-j0W.jpg)
PBC NASH on Twitter: "ARREST: Phase IIb trial of aramchol in noncirrhotic patients with NASH is under way. #PBCNASH http://t.co/nESuRWVrrF" / Twitter
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive5.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/Diapositive1.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive3.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9cd9ea41-6b34-48c7-8e3d-300df6aba7d1/gr1_lrg.jpg)
The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology
![Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fd901273-201f-4686-9a36-ca8df4a840bb/fx1_lrg.jpg)
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis - JHEP Reports
![Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology](https://www.frontiersin.org/files/Articles/603926/fphar-11-603926-HTML-r1/image_m/fphar-11-603926-g001.jpg)
Frontiers | Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments | Pharmacology
![One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients](https://www.natap.org/2018/images%20/121218/121218-4/1212185.gif)
One-year results of the Global Phase 2b randomized placebo-controlled ARREST Trial of Aramchol, a Stearoyl CoA Desaturasemodulator in NASH patients
![New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism - European Medical Journal New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/02/figure-1.jpg)
New Data on Aramchol TM for the Treatment of Non-alcoholic Steatohepatitis: Exploring Potential for Greater Efficacy and the Effect on Glucose Metabolism - European Medical Journal
![Identification of serum biomarkers associated with Aramchol treatment.... | Download Scientific Diagram Identification of serum biomarkers associated with Aramchol treatment.... | Download Scientific Diagram](https://www.researchgate.net/profile/Marta-Iruarrizaga/publication/320219916/figure/fig2/AS:614294492299297@1523470628971/Identification-of-serum-biomarkers-associated-with-Aramchol-treatment-A-Volcano-plot.png)
Identification of serum biomarkers associated with Aramchol treatment.... | Download Scientific Diagram
![Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-021-01495-3/MediaObjects/41591_2021_1495_Fig1_HTML.png)
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial | Nature Medicine
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://hcv-trials.com/nash/Aramchol_Abs_LB5/big/Diapositive2.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
![IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML IJERPH | Free Full-Text | Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives | HTML](https://www.mdpi.com/ijerph/ijerph-16-04334/article_deploy/html/images/ijerph-16-04334-g001.png)